跳至主要内容
临床试验/NL-OMON22078
NL-OMON22078尚未招募不适用

An integrated optimization of surgery and radiotherapy techniques to improve cosmetic outcome and quality of life in breast conserving therapy for breast cancer patients

Erasmus MC0 个研究点目标入组 750 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Erasmus MC
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Female patients aged = 18 years
  • History of BCT with adjuvant radiation therapy for non-metastatic, histologically proven invasive breast cancer (pT1-3N0-2a) or DCIS. In light of BCT adjuvant systemic treatment (i.e. endocrine therapy, chemotherapy and immune therapy) is allowed.
  • Breast conserving surgery between 1st of January 2016 and 31th of December 2018
  • Treated according to the currently applied dose fractionation schedules, i.e. whole breast radiotherapy, with or without boost
  • Adequate understanding of the Dutch language and written informed consent

排除标准

  • Any breast surgery or re-irradiation on the breast area after BCT
  • Progression of disease (and additional treatment) since BCT
  • Patients who received partial breast irradiation
  • Current pregnancy or breast feeding

研究者

发起方
Erasmus MC

相似试验